Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients.

Kanefendt, F., Lindauer, A., Kinzig, M., Strumberg, D., Scheulen, M.E., Mross, K., Fischer, R., Moritz, B., Sörgel, F., Jaehde, U., 2011.

Int J Clin Pharmacol Ther 49, 88–90.

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: - / Journal: International Journal of Clinical Pharmacology and Therapeutics
CESAR-C-II-005
2011
Capecitabine (Cap) combined with bevacizumab (Bev) with or without vinorelbine (Vin) in first-line metastatic breast cancer (MBC): First safety results from the randomized CARIN trial.

Hegewisch-Becker, S., Lerchenmüller, C.A., Welt, A., Decker, T., Just, M., Steffens, C., Hipper, A., Marschner, N., 2011.

J Clin Oncol (Meeting Abstracts). 2011;29(suppl; abstract 1044). doi: 10.1200/jco.2011.29.15_suppl.1044

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ASCO / Journal: Journal of Clinical Oncology
CARIN
2011
Treatment of patients with Multiple Myeloma Routine treatment by office-based haematologists in Germany – Data from the Tumour Registry Lymphatic Neoplasms.

Hartmann, H., Knauf, W., Abenhardt, W., Aldaoud, A., Lerchenmüller, C., Koska, M., 2011.

ISPOR 14th Annual European Congress. Cancer: Clinical Outcomes Studies.

Download

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ISPOR / Journal: -
TLN
2011
Die Behandlungsrealität von Patienten mit metastasiertem Nierenzellkarzinom in Deutschland – Update aus dem RCC-Register.

Goebell, P.J., Müller, L., Blumenstengel, K., Hübner, A., Lück, A., Koska, M., Marschner, N., 2011.

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: DGU / Journal: -
TNK
2011
Survival and palliative treatment course of colorectal cancer patients in German outpatient centres. Data from the clinical registry – TKK Registry.

Freier, W., Rauh, J., Kindler, M., Jänicke, M., Marschner, N., 2011.

Onkologie 34 (suppl 6)(V643), 189. doi:10.1159/000333303

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: DGHO / Journal: Onkologie
TKK
2011
EGFR mutation testing and first line treatment of patients with advanced NSCLC and positive EGFR mutation status: results from a German registry.

Eberhardt, W., Thomas, M., Graf von der Schulenburg, J.-M., Dietel, M., Schirmacher, P., Gutendorf, P., Zirrgiebel, U., Schütte, W., 2011.

EMCC / ESMO, European Multidisciplinary Cancer Congress, Stockholm (Poster 133), 664.

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: EMCC (ESMO) / Journal: -
REASON
2011
REASON: A Registry for the Epidemiologic and Scientific evaluation of EGFR mutation status in newly diagnosed NSCLC patients stage IIIB/IV.

Dietel, M., Schütte, W., Thomas, M., Eberhardt, W., Graf von der Schulenburg, J.-M., Schirmacher, P., 2011.

Indikation: Lung Cancer, Lungenkarzinom / Veranstaltung: DGP / Journal: -
REASON
2011
First line therapy with Bendamustine in advanced indolent Non-Hodgkin Lymphoma in treatment routine – interim analysis of the non-interventional study Be-1st.

Becker, M., Tschechne, B., Reeb, M., Schwinger, U., Grass, J., Straßl, L., 2011.

Onkologie 34 (suppl.6)(P891), 268. doi:10.1159/000333305

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: DGHO / Journal: Onkologie
Be-1st
2011
Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial.

Bartlett, J.M.S., Brookes, C.L., Robson, T., van de Velde, C.J.H., Billingham, L.J., Campbell, F.M., Grant, M., Hasenburg, A., Hille, E.T.M., Kay, C., Kieback, D.G., Putter, H., Markopoulos, C., Kranenbarg, E.M.-K., Mallon, E.A., Dirix, L., Seynaeve, C., Rea, D., 2011.

J Clin Oncol 29, 1531–1538. doi:10.1200/JCO.2010.30.3677

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Journal of Clinical Oncology
TEAM
2011
Tumorregister Lymphatische Neoplasien (TLN) der niedergelassenen Hämato-/Onkologen in Deutschland.

Abenhardt, W., Knauf, W., 2011.

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: Lymphom-Meeting / Journal: -
TLN
2011